• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘌呤能P2Y受体的氧化还原依赖性内化限制结肠炎进展。

Redox-dependent internalization of the purinergic P2Y receptor limits colitis progression.

作者信息

Nishiyama Kazuhiro, Nishimura Akiyuki, Shimoda Kakeru, Tanaka Tomohiro, Kato Yuri, Shibata Takahiro, Tanaka Hiroshi, Kurose Hitoshi, Azuma Yasu-Taka, Ihara Hideshi, Kumagai Yoshito, Akaike Takaaki, Eaton Philip, Uchida Koji, Nishida Motohiro

机构信息

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.

出版信息

Sci Signal. 2022 Jan 11;15(716):eabj0644. doi: 10.1126/scisignal.abj0644.

DOI:10.1126/scisignal.abj0644
PMID:35015570
Abstract

After ligand stimulation, many G protein–coupled receptors (GPCRs) undergo β-arrestin–dependent desensitization, during which they are internalized and either degraded or recycled to the plasma membrane. Some GPCRs are not subject to this type of desensitization because they lack the residues required to interact with β-arrestins. We identified a mechanism of redox-dependent alternative internalization (REDAI) that promotes the internalization and degradation of the purinergic P2Y receptor (P2YR). Synthetic and natural compounds containing electrophilic isothiocyanate groups covalently modified P2YR at Cys, which promoted the ubiquitylation of Lys and receptor internalization and degradation in various mouse and human cultured cell lines. Endogenous electrophiles also promoted ligand-dependent P2YR internalization and degradation. P2YR is highly abundant in inflammatory cells and promotes the pathogenesis of colitis. Deficiency in P2YR protected mice against experimentally induced colitis, and mice expressing a form of P2YR in which Cys was mutated to nonmodifiable serine were more sensitive to the induction of colitis. Several other GPCRs, including AAR, contain cysteine and lysine residues at the appropriate positions to mediate REDAI, and isothiocyanate stimulated the internalization of AAR and of a form of P2YR with insertions of the appropriate residues. Thus, endogenous and exogenous electrophiles may limit colitis progression through cysteine modification of P2YR and may also mediate internalization of other GPCRs.

摘要

配体刺激后,许多G蛋白偶联受体(GPCR)会经历β-抑制蛋白依赖性脱敏,在此过程中它们会被内化,然后降解或再循环至质膜。一些GPCR不会发生这种类型的脱敏,因为它们缺乏与β-抑制蛋白相互作用所需的残基。我们发现了一种氧化还原依赖性替代内化(REDAI)机制,该机制促进嘌呤能P2Y受体(P2YR)的内化和降解。含有亲电异硫氰酸酯基团的合成和天然化合物在半胱氨酸处共价修饰P2YR,这促进了赖氨酸的泛素化以及受体在各种小鼠和人类培养细胞系中的内化和降解。内源性亲电试剂也促进了配体依赖性P2YR的内化和降解。P2YR在炎症细胞中高度丰富,并促进结肠炎的发病机制。P2YR缺陷可保护小鼠免受实验性诱导的结肠炎影响,而表达半胱氨酸突变为不可修饰丝氨酸形式的P2YR的小鼠对结肠炎的诱导更敏感。其他几种GPCR,包括AAR,在适当位置含有半胱氨酸和赖氨酸残基以介导REDAI,异硫氰酸酯刺激了AAR和具有适当残基插入的P2YR形式的内化。因此,内源性和外源性亲电试剂可能通过对P2YR的半胱氨酸修饰来限制结肠炎的进展,并且还可能介导其他GPCR的内化。

相似文献

1
Redox-dependent internalization of the purinergic P2Y receptor limits colitis progression.嘌呤能P2Y受体的氧化还原依赖性内化限制结肠炎进展。
Sci Signal. 2022 Jan 11;15(716):eabj0644. doi: 10.1126/scisignal.abj0644.
2
[Covalent drug discovery targeting G protein-coupled receptors].靶向G蛋白偶联受体的共价药物发现
Nihon Yakurigaku Zasshi. 2022;157(5):356-360. doi: 10.1254/fpj.22045.
3
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension.嘌呤能P2Y6受体与血管紧张素AT1受体形成异源二聚体,以促进血管紧张素II诱导的高血压。
Sci Signal. 2016 Jan 19;9(411):ra7. doi: 10.1126/scisignal.aac9187.
4
The role of P2Y receptor in the pathogenesis of cardiovascular and inflammatory diseases.P2Y 受体在心血管和炎症性疾病发病机制中的作用。
J Pharmacol Sci. 2024 Feb;154(2):108-112. doi: 10.1016/j.jphs.2024.01.003. Epub 2024 Jan 5.
5
Purinergic receptor P2Y6 contributes to 1-methyl-4-phenylpyridinium-induced oxidative stress and cell death in neuronal SH-SY5Y cells.嘌呤能受体 P2Y6 有助于 1-甲基-4-苯基吡啶离子诱导的神经元 SH-SY5Y 细胞氧化应激和细胞死亡。
J Neurosci Res. 2018 Feb;96(2):253-264. doi: 10.1002/jnr.24119. Epub 2017 Jul 28.
6
Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists.P2Y6受体激动剂增强小鼠骨骼肌细胞和脂肪细胞对葡萄糖的摄取。
PLoS One. 2014 Dec 30;9(12):e116203. doi: 10.1371/journal.pone.0116203. eCollection 2014.
7
The role of P2YR in cardiovascular diseases and recent development of P2YR antagonists.P2YR在心血管疾病中的作用及P2YR拮抗剂的最新进展。
Drug Discov Today. 2020 Mar;25(3):568-573. doi: 10.1016/j.drudis.2019.12.015. Epub 2020 Jan 8.
8
The G protein-coupled P2Y₆ receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis.G 蛋白偶联 P2Y₆ 受体通过抑制细胞凋亡促进结直肠肿瘤发生。
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1539-1551. doi: 10.1016/j.bbadis.2018.02.008. Epub 2018 Feb 14.
9
beta-Arrestin-2 interaction and internalization of the human P2Y1 receptor are dependent on C-terminal phosphorylation sites.β-抑制蛋白2与人P2Y1受体的相互作用及内化依赖于C末端磷酸化位点。
Mol Pharmacol. 2009 Dec;76(6):1162-71. doi: 10.1124/mol.109.060467. Epub 2009 Sep 9.
10
Modulation of P2YR expression exacerbates pressure overload-induced cardiac remodeling in mice.P2YR 表达的调节加剧了小鼠压力超负荷诱导的心脏重构。
Sci Rep. 2020 Aug 18;10(1):13926. doi: 10.1038/s41598-020-70956-5.

引用本文的文献

1
Macrophage P2YR activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses.巨噬细胞P2YR激活通过IL-27介导的Th1反应加重银屑病炎症。
Acta Pharm Sin B. 2024 Oct;14(10):4360-4377. doi: 10.1016/j.apsb.2024.06.008. Epub 2024 Jun 20.
2
The microglial P2Y receptor as a therapeutic target for neurodegenerative diseases.小胶质细胞 P2Y 受体作为神经退行性疾病的治疗靶点。
Transl Neurodegener. 2024 Sep 7;13(1):47. doi: 10.1186/s40035-024-00438-5.
3
Functionalized Congeners of 2-Chromene P2Y Receptor Antagonists.
2-色烯 P2Y 受体拮抗剂的功能化同系物。
Cells. 2024 Aug 16;13(16):1366. doi: 10.3390/cells13161366.
4
A adenosine receptor signaling and regulation.A 腺苷受体信号传导与调节。
Purinergic Signal. 2025 Apr;21(2):201-220. doi: 10.1007/s11302-024-10025-y. Epub 2024 Jun 4.
5
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics.对嘌呤能P2受体在疾病中的潜在作用的全面见解:涉及的信号通路及潜在治疗方法。
J Adv Res. 2025 Mar;69:427-448. doi: 10.1016/j.jare.2024.03.027. Epub 2024 Mar 31.
6
Machine learning-aided search for ligands of P2Y and other P2Y receptors.基于机器学习的 P2Y 及其他 P2Y 受体配体的搜索。
Purinergic Signal. 2024 Dec;20(6):617-627. doi: 10.1007/s11302-024-10003-4. Epub 2024 Mar 25.
7
Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression.TRPC6 通道的药理学激活可预防结肠炎进展。
Int J Mol Sci. 2024 Feb 18;25(4):2401. doi: 10.3390/ijms25042401.
8
GPCR kinases differentially modulate biased signaling downstream of CXCR3 depending on their subcellular localization.G 蛋白偶联受体激酶(GPCR kinases)根据其亚细胞定位的不同,差异调节 CXCR3 下游的偏向信号。
Sci Signal. 2024 Feb 13;17(823):eadd9139. doi: 10.1126/scisignal.add9139.
9
New paradigms in purinergic receptor ligand discovery.嘌呤能受体配体发现的新范式。
Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13.
10
Knockout of Purinergic P2Y Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis.嘌呤能 P2Y 受体敲除未能改善非酒精性脂肪性肝炎中的肝损伤和炎症。
Int J Mol Sci. 2023 Feb 14;24(4):3800. doi: 10.3390/ijms24043800.